White paper: The next step to automating clinical trials
Document
Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.
However, there are new solutions that digitize manual processes, resulting in reduced site burden, timely kit level data for study teams, and ensuring safe delivery right to the patient.
What is on this page?
Click to jump to a specific section below.
Automating Clinical Trials
“You can say that if you meet all the needs of clinical you would meet all the needs of commercial, but you can’t say the inverse - you can’t say that if you meet all commercial needs, you’d satisfy all the regulatory requirements of a clinical setting.”
So argues Evan Hahn, VP of TSS North America, making the point that perhaps we’re guilty of offering similar solutions for both clinical and commercial distribution streams when their requirements - although they share certain elements - are ultimately different.
Download this white paper where Evan Hahn, VP TSS North America, Tobias Holmer CPO at TSS, and Cat Hall, VP of Clinical Innovation and Quality at Endpoint Clinical discuss how automating Clinical Trials and tight technical integrations are key to increasing the rate of successful outcomes of clinical trials, while also speeding up the whole clinical process.
You may also be interested in
GCSG 2023 US Conference
Where do the majority of your temperature excursions occur? Why not eliminate them?
Read moreDownload Whitepaper
Logipharma report: A fast-track learning exercise in pharma supply chain innovation
In Q4 of 2021, WBR Insights surveyed 100 Directors of Supply Chain Management and similar from pharma organizations across Europe and North America to find out about the challenges they face in 2021 and the innovative solutions they are putting in place.
Read moreDownload Whitepaper
Cooperation with Swedish Innovation Authority and University to Optimize Sustainability Procedures
Loggers with reusable components can decrease the carbon footprint by almost 90% compared to disposable. These important discoveries were made during a close collaboration between business, research, and authorities to prepare for more environmentally and socially sustainable business practices.
Read moreDownload WhitepaperYou may also be interested in
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
Extending TempMonitor BLE to Ultra-Low Temperatures
Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more